Downregulation of CD4+LAP+ and CD4+CD25+ regulatory T cells in acute coronary syndromes

Ying-zhong Lin1, Shan-he Lu1, Zheng-de Lu1

  • 1Department of Cardiology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.

Insights

Regulatory T (Treg) cells, including CD4+LAP+ Tregs, are decreased in acute coronary syndromes (ACS). This reduction in regulatory T cells and associated cytokines may contribute to ACS onset.

Area of Science:

  • Immunology
  • Cardiology
  • Molecular Biology

Background:

  • Regulatory T (Treg) cells are crucial in atherosclerosis and acute coronary syndromes (ACS).
  • CD4+LAP+ Treg cells, a novel subset, show promise in ameliorating atherosclerosis and are present in humans.
  • The study investigates the role of CD4+LAP+ Treg cells in the onset of ACS.

Purpose of the Study:

  • To determine the involvement of CD4+LAP+ Treg cells in the onset of acute coronary syndromes (ACS).
  • To compare frequencies of CD4+LAP+ and CD4+CD25+ Treg cells in ACS patients versus controls.

Main Methods:

  • Flow cytometry was used to quantify CD4+LAP+ and CD4+CD25+ Treg cell frequencies.
  • ELISA measured plasma levels of IL-10 and TGF-β1.
  • Study included patients with stable angina (SA), non-ST-elevation ACS (NSTEACS), ST-elevation myocardial infarction (STEMI), and healthy controls.

Main Results:

  • Patients with ACS exhibited significantly lower frequencies of CD4+LAP+ and CD4+CD25+ Treg cells compared to SA and control groups.
  • Reduced levels of IL-10 and TGF-β1 were observed in ACS patients.
  • A significant decrease in regulatory T cell populations and key cytokines was noted in ACS.

Conclusions:

  • A diminished frequency of CD4+LAP+ and CD4+CD25+ Treg cells may be implicated in the pathogenesis of ACS.
  • The findings suggest a potential role for these Treg subsets in ACS development.
Abstract

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K